Paper Details

  1. Home
  2. Paper Details

Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol.

Author: BrandonM L, GriecoM, HudsonL, RosenthalR R, SpectorS L, TashkinD, TinkelmanD G, VotteriB

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Pirbuterol and metaproterenol are beta-2 selective beta agonists used to treat asthma. This study compared the safety and efficacy of these agents in 133 asthmatic patients for 12 weeks. There were no significant differences in clinical efficacy, onset of action, peak effect, side effects, or development of tolerance between the two agents.
Paper Details　
Original Abstract of the Article :
This multicenter study was performed to compare the safety and efficacy of a new beta-2 selective beta agonist, pirbuterol, with metaproterenol. The study followed a double-blind parallel design evaluating 133 asthmatic patients for 12 weeks. There were essentially no clinical differences between gr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2405746

データ提供：米国国立医学図書館（NLM）

Comparing Inhaled Beta-2 Agonists for Asthma Treatment

This multicenter study compares the safety and efficacy of two inhaled beta-2 selective agonists, pirbuterol and metaproterenol, in treating asthma. The researchers conducted a double-blind, parallel design study to evaluate the effectiveness and safety of these drugs in patients with asthma over a 12-week period.

Pirbuterol: A Safe and Effective Alternative for Asthma Management

The study finds that pirbuterol is at least as effective and safe as metaproterenol for chronic asthma management. This research offers valuable insights into the therapeutic potential of pirbuterol as an alternative treatment option for asthma, providing patients with more choices for managing their condition. Imagine a vast desert filled with the challenges of asthma. Pirbuterol, like a sturdy camel, provides a safe and reliable way to navigate the terrain of this chronic condition.

Navigating the Complexities of Asthma

Asthma is a complex respiratory condition that can significantly impact a person's quality of life. This research emphasizes the importance of understanding the effectiveness and safety of different treatment options, allowing patients to make informed decisions about their care.

Dr. Camel's Conclusion

This research is like a well-traveled path across the desert, guiding us towards a better understanding of asthma treatment options. By comparing the efficacy and safety of pirbuterol and metaproterenol, this study provides valuable insights for making informed decisions about asthma management.

Date :
  1. Date Completed 1990-03-14
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2405746

DOI: Digital Object Identifier

2405746

Related Literature

Article Analysis
・Side Effects of metaproterenol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.